Related Experiment Video
Updated: Jun 17, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
[Regulation (EC) No. 1394/2007 on advanced therapy medicinal products : Incorporation into national law]
A Dwenger1, J Strassburger, W Schwerdtfeger
1Bundesministerium für Gesundheit, Rochusstr. 1, 53123, Bonn.
Abstract:
Regulation (EC) No. 1394/2007 has created a new legal framework for advanced therapy medicinal products (gene therapy medicinal products, somatic cell therapy medicinal products and tissue engineered products). The Regulation is directly applicable in the Member States of the European Union and, in principle, requires no incorporation into national law. However, the amendment of Directive 2001/83/EC, which results from Regulation (EC) No. 1394/2007, has created a need for incorporation into and amendment of the German Medicinal Products Act. This is one of the objectives of the 15th amendment of the German Medicinal Products Act. In particular, the definition "advanced therapy medicinal products" and the special provisions for advanced therapy medicinal products prepared on a non-routine basis, which are based on the special provisions contained in Art. 28 No. 2 of Regulation (EC) No. 1394/2007, are to be incorporated into the German Medicinal Products Act. These special provisions will be explained in detail.
More Related Videos
Related Concept Videos
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Dosage Regimen: Individualization
Microorganisms in Medicine and Therapeutics
Therapeutic Drug Monitoring: Overview and Classification

